Cytalux Approved to Detect Ovarian Cancer Lesions During Surgery
Cytalux is a fluorescent drug intended to assist surgeons in identifying ovarian cancer lesions.
Ovarian Cancer
Nemvaleukin Alfa Plus Pembrolizumab Fast Tracked for Platinum-Resistant Ovarian Cancer
The antitumor activity and safety of nemvaleukin alfa plus pembrolizumab is being investigated in the open-label, randomized, phase 3 ARTISTRY-7 trial.
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Findings seen in BRCA1 and BRCA2 mutation carriers; reduction greater with longer duration of use in BRCA1 carriers
Presence of Particulate Prompts Recall of Topotecan Injection
To date, Teva has not received any further complaints or adverse events reports related to this recall.
Carboplatin Alone Not Adequate for Ovarian Cancer in Frail Seniors
Worse survival than with combination carboplatin-paclitaxel regimens for vulnerable older patients with ovarian cancer
Pafolacianine Sodium Gets Priority Review for Ovarian Cancer Detection During Surgery
Pafolacianine sodium binds to folate receptors commonly found on many cancers, including ovarian and lung cancers, and illuminates the cancerous lesions under near-infrared light.
Sales of Johnson’s Baby Powder Halted in US, Canada
Johnson & Johnson says talc-based powder is safe and will still be sold in other countries.
Lynparza Plus Bevacizumab Approved for First-Line Maintenance in HRD-Positive Advanced Ovarian Cancer
The FDA has approved Lynparza® for use in combination with bevacizumab as first-line maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer
Zejula Approved for Maintenance Treatment of Advanced Ovarian Cancer
Results showed a statistically significant improvement in PFS for Zejula compared with placebo, regardless of biomarker status.
ASCO Guideline: Germline Testing Recommended for All Women Diagnosed With Epithelial Ovarian Cancer
A pervading theme of this guideline was the importance of including genetic counselors in the interpretation and communication of germline and somatic testing results.
